{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:11:45Z","timestamp":1780333905242,"version":"3.54.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Bavarian Genome Research Project","award":["#3"],"award-info":[{"award-number":["#3"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.clinbiochem.2015.05.007","type":"journal-article","created":{"date-parts":[[2015,5,13]],"date-time":"2015-05-13T02:34:57Z","timestamp":1431484497000},"page":"781-787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Quantification of mevalonate-5-phosphate using UPLC-MS\/MS for determination of mevalonate kinase activity"],"prefix":"10.1016","volume":"48","author":[{"given":"Lukas","family":"Reitzle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Stojanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Teupser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ania C.","family":"Muntau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Vogeser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren W.","family":"Gersting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.clinbiochem.2015.05.007_bb0005","doi-asserted-by":"crossref","first-page":"18134","DOI":"10.1074\/jbc.M200912200","article-title":"The structure of a binary complex between a mammalian mevalonate kinase and ATP: insights into the reaction mechanism and human inherited disease","volume":"277","author":"Fu","year":"2002","journal-title":"J Biol Chem"},{"issue":"18","key":"10.1016\/j.clinbiochem.2015.05.007_bb0010","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1016\/S0021-9258(18)93170-4","article-title":"The inhibition of mevalonic kinase by geranyl and farnesyl pyrophosphates","volume":"243","author":"Dorsey","year":"1968","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.clinbiochem.2015.05.007_bb0015","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.bbalip.2011.01.002","article-title":"Inhibition of the isoprenoid biosynthesis pathway; detection of intermediates by UPLC-MS\/MS","volume":"1811","author":"Henneman","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.clinbiochem.2015.05.007_bb0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1172-1-13","article-title":"Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome","volume":"1","author":"Haas","year":"2006","journal-title":"Orphanet J Rare Dis"},{"issue":"1\u20133","key":"10.1016\/j.clinbiochem.2015.05.007_bb0025","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1388-1981(00)00135-9","article-title":"Biochemical and genetic aspects of mevalonate kinase and its deficiency","volume":"1529","author":"Houten","year":"2000","journal-title":"Biochim Biophys Acta"},{"issue":"25","key":"10.1016\/j.clinbiochem.2015.05.007_bb0030","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1093\/hmg\/11.25.3115","article-title":"Temperature dependence of mutant mevalonate kinase activity as a pathogenic factor in hyper-IgD and periodic fever syndrome","volume":"11","author":"Houten","year":"2002","journal-title":"Hum Mol Genet"},{"issue":"8","key":"10.1016\/j.clinbiochem.2015.05.007_bb0035","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/humu.20361","article-title":"Mutational spectrum and genotype-phenotype correlations in mevalonate kinase deficiency","volume":"27","author":"Mandey","year":"2006","journal-title":"Hum Mutat"},{"issue":"6","key":"10.1016\/j.clinbiochem.2015.05.007_bb0040","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/MD.0b013e318190cfb7","article-title":"Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome","volume":"87","author":"van der Hilst","year":"2008","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.clinbiochem.2015.05.007_bb0045","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1542\/peds.91.5.915","article-title":"Clinical and biochemical phenotype in 11 patients with mevalonic aciduria","volume":"91","author":"Hoffmann","year":"1993","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.clinbiochem.2015.05.007_bb0050","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1542\/peds.2010-3639","article-title":"Mevalonate kinase deficiency: a survey of 50 patients","volume":"128","author":"Bader-Meunier","year":"2011","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.clinbiochem.2015.05.007_bb0055","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1002\/art.20264","volume":"50","author":"Stojanov","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.clinbiochem.2015.05.007_bb0060","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/BF01800016","article-title":"Mevalonate kinase assay using DEAE-cellulose column chromatography for first-trimester prenatal diagnosis and complementation analysis in mevalonic aciduria","volume":"15","author":"Hoffmann","year":"1992","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"10.1016\/j.clinbiochem.2015.05.007_bb0070","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/nar\/gkg031","article-title":"INFEVERS: the Registry for FMF and hereditary inflammatory disorders mutations","volume":"31","author":"Sarrauste de Menthiere","year":"2003","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.clinbiochem.2015.05.007_bb0075","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0009-8981(91)90355-G","article-title":"Facts and artefacts in mevalonic aciduria: development of a stable isotope dilution GCMS assay for mevalonic acid and its application to physiological fluids, tissue samples, prenatal diagnosis and carrier detection","volume":"198","author":"Hoffmann","year":"1991","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.clinbiochem.2015.05.007_bb0080","series-title":"FDA Guidance for Industry: Bioanalytical Method Validation","author":"Food and Drug Administration","year":"2001"},{"issue":"7","key":"10.1016\/j.clinbiochem.2015.05.007_bb0085","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1373\/49.7.1041","article-title":"Ion suppression in mass spectrometry","volume":"49","author":"Annesley","year":"2003","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.clinbiochem.2015.05.007_bb0090","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ab.2008.08.023","article-title":"Detection of nonsterol isoprenoids by HPLC-MS\/MS","volume":"383","author":"Henneman","year":"2008","journal-title":"Anal Biochem"},{"issue":"41","key":"10.1016\/j.clinbiochem.2015.05.007_bb0095","doi-asserted-by":"crossref","first-page":"25449","DOI":"10.1074\/jbc.272.41.25449","article-title":"Identification of catalytic residues in human mevalonate kinase","volume":"272","author":"Potter","year":"1997","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.clinbiochem.2015.05.007_bb0100","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1021\/bi7024386","article-title":"Biochemical and structural basis for feedback inhibition of mevalonate kinase and isoprenoid metabolism","volume":"47","author":"Fu","year":"2008","journal-title":"Biochemistry"},{"issue":"42","key":"10.1016\/j.clinbiochem.2015.05.007_bb0105","doi-asserted-by":"crossref","first-page":"26756","DOI":"10.1074\/jbc.272.42.26756","article-title":"Identification of an active site alanine in mevalonate kinase through characterization of a novel mutation in mevalonate kinase deficiency","volume":"272","author":"Hinson","year":"1997","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.clinbiochem.2015.05.007_bb0110","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000469050","article-title":"Mevalonate kinase in lysates of cultured human fibroblasts and lymphoblasts: kinetic properties, assay conditions, carrier detection and measurement of residual activity in a patient with mevalonic aciduria","volume":"41","author":"Gibson","year":"1989","journal-title":"Enzyme"},{"issue":"4","key":"10.1016\/j.clinbiochem.2015.05.007_bb0115","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10545-014-9701-z","article-title":"Innovative strategies to treat protein misfolding in inborn errors of metabolism: pharmacological chaperones and proteostasis regulators","volume":"37","author":"Muntau","year":"2014","journal-title":"J Inherit Metab Dis"},{"issue":"26","key":"10.1016\/j.clinbiochem.2015.05.007_bb0120","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa021654","article-title":"Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria","volume":"347","author":"Muntau","year":"2002","journal-title":"N Engl J Med"},{"issue":"5607","key":"10.1016\/j.clinbiochem.2015.05.007_bb0125","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1126\/science.1079589","article-title":"Prevention of transthyretin amyloid disease by changing protein misfolding energetics","volume":"299","author":"Hammarstrom","year":"2003","journal-title":"Science"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912015001757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912015001757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:45:51Z","timestamp":1757864751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912015001757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0009912015001757"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.05.007","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification of mevalonate-5-phosphate using UPLC-MS\/MS for determination of mevalonate kinase activity","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}